Department of Neurosurgery, Sir Ganga Ram Hospital, Delhi, India.
Neurol India. 2022 Jul-Aug;70(4):1412-1416. doi: 10.4103/0028-3886.355155.
Microvascular decompression (MVD) of the trigeminal nerve is a well-accepted nondestructive procedure for trigeminal neuralgia. Usually, Teflon (PTFE) puff or felt graft techniques, which are most commonly used, are associated with arachnoiditis and recurrence among other complications. We use the "sleeve graft" technique using PTFE to separate the neurovascular conflict and here we describe our experience with the same in 376 cases.
To study the outcomes in 376 patients treated with sleeve graft technique for trigeminal neuralgia.
For a period of 18 years, from 2002 to 2020, all cases of medically refractory trigeminal neuralgia were subjected to the "sleeve graft" technique for MVD. Pre- and post-operatively, pain score was given according to Barrow Neurological Institute pain intensity score. Cases were observed for any complications and pain relief in short and long-term follow-up.
In total, 376 cases of refractory primary trigeminal neuralgia cases, among which 198 patients underwent MVD with no prior intervention, 158 underwent MVD following percutaneous ablative procedure, 13 were "Revision MVD" previously done at other centers, and four were post gamma knife failure. There was no incidence of arachnoiditis or recurrence of symptoms. Further, 368 (97.8%) patients had complete recovery from symptoms while eight (2.2%) had partial recovery after 5 years of follow-up. Complications included hearing loss (n = 1), temporary hypoesthesia (n = 45), and permanent hypoesthesia (n = 7).
"PTFE Sleeve Graft" technique to remove the neurovascular conflict in micro vascular decompression (MVD) for trigeminal neuralgia is a safe and effective technique that yields better results.
三叉神经微血管减压术(MVD)是治疗三叉神经痛的一种公认的非破坏性手术。通常,最常使用的 Teflon(PTFE)泡芙或毡移植技术与蛛网膜炎和复发等并发症有关。我们使用 PTFE 分离神经血管冲突的“套管移植”技术,在此我们描述了在 376 例患者中使用相同技术的经验。
研究 376 例采用套管移植技术治疗三叉神经痛的患者的治疗效果。
在 18 年期间(2002 年至 2020 年),所有药物难治性三叉神经痛患者均接受 MVD 的“套管移植”技术治疗。根据巴罗神经研究所疼痛强度评分,在术前和术后给予疼痛评分。观察所有病例的短期和长期随访中的任何并发症和疼痛缓解情况。
共有 376 例难治性原发性三叉神经痛患者,其中 198 例患者在无前期干预的情况下接受了 MVD,158 例患者在经皮消融术后接受了 MVD,13 例患者在其他中心进行了“修订 MVD”,4 例患者伽玛刀治疗失败。没有发生蛛网膜粘连或症状复发。进一步,368(97.8%)例患者症状完全缓解,8(2.2%)例患者在 5 年随访后部分缓解。并发症包括听力损失(n = 1),短暂性感觉迟钝(n = 45)和永久性感觉迟钝(n = 7)。
在三叉神经痛微血管减压术(MVD)中,使用 PTFE 套管移植技术去除神经血管冲突是一种安全有效的技术,可获得更好的效果。